Literature DB >> 3030343

Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.

T Katsuki, K Yamaguchi, Y Matsuoka, Y Hinuma.   

Abstract

The abilities of peripheral blood lymphocytes from 9 patients with adult T-cell leukemia (ATL) and 14 healthy control adults to cause regression of proliferating B-cell foci induced by Epstein-Barr virus (EBV) were examined. Marked regression of EBV-transformed B-cell foci was observed in lymphocytes from all 10 EBV-seropositive donors but with none of those of the 4 EBV-seronegative donors in the control group. The lymphocyte of all 9 patients with ATL, who were EBV-seropositive, caused little or no regression of B-cell foci like those of EBV-negative healthy donors. These results suggest that the absence of regression of EBV-induced B-cell proliferation observed in ATL patients is due to impairment of EBV-specific killer T-cell activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030343

Source DB:  PubMed          Journal:  AIDS Res        ISSN: 0737-6006


  5 in total

1.  Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells.

Authors:  Girish Venkataraman; Jonathan Berkowitz; John C Morris; John E Janik; Mark A Raffeld; Stefania Pittaluga
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

2.  Prevalence of human T cell lymphotropic virus 1 infection in Canada.

Authors:  L Amar; M Le; F M Ghazawi; E Rahme; A Segal; E Netchiporouk; G Popradi; L Moreau; O Roshdy; D Sasseville; I V Litvinov
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

3.  Frequent lack of antibodies against human T-cell leukemia virus type I gag proteins p24 or p19 in sera of patients with adult T-cell leukemia.

Authors:  N Suetake; Y Takeuchi; N Shimizu; H Uesato; T Kuroume; H Hoshino
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.

Authors:  Elena Netchiporouk; Jennifer Gantchev; Matthew Tsang; Philippe Thibault; Andrew K Watters; John-Douglas Matthew Hughes; Feras M Ghazawi; Anders Woetmann; Niels Ødum; Denis Sasseville; Ivan V Litvinov
Journal:  Oncotarget       Date:  2017-10-07

5.  Impaired long-term T cell immunity to Epstein-Barr virus in patients with nasopharyngeal carcinoma.

Authors:  S Tamura; A Yamazaki; M Kunimoto; K Takemura; T Tabata; Y Hinuma; O Yoshie
Journal:  Jpn J Cancer Res       Date:  1992-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.